Category: Nootropic / Coffee / Cognitive | Evidence Grade: B | Form: Instant Coffee Blend
V-NEUROKAFE is a nootropic-enhanced instant coffee that combines the immediate alertness benefits of Arabica caffeine with three clinically studied cognitive enhancers: Bacopa Monnieri, Phosphatidylserine, and Ginkgo Biloba. This unique formulation targets multiple cognitive domains simultaneously — memory consolidation, mental processing speed, sustained attention, and neuroprotection.
Unlike conventional coffee that provides a short-lived energy spike followed by a crash, V-NEUROKAFE delivers a two-phase cognitive experience: acute enhancement of focus and alertness from caffeine, coupled with progressive improvements in memory and cognitive function from the nootropic stack over 8-12 weeks of consistent use.
The formula is specifically designed for three populations with the strongest evidence of benefit:
V-NEUROKAFE transforms the daily coffee ritual into a strategic cognitive enhancement practice. Each sachet delivers precise, therapeutically-relevant doses of all four active ingredients, ensuring consistency that single-ingredient supplements often lack.
Each ingredient in V-NEUROKAFE was carefully selected for its evidence-based benefits and synergistic effects.
Value
Amount
Per Serving
Proprietary Blend
† Daily Value not established.
Total Carbohydrate
Thiamin (as Thiamine HCl)
Vitamin B6 (as Pyridoxine HCl)
2.69 g
2 g
15 mg
10 mg
<1%*
Instant Roasted Black Coffee (Coffea arabica) (Bean)
Bacillus coagulans
V-NEUROKAFE's four-ingredient nootropic stack delivers benefits across multiple cognitive domains:
V-NEUROKAFE's formula is supported by 8 peer-reviewed, PubMed-indexed clinical studies examining its active ingredients in human subjects.
| PubMed ID | Ingredient | Key Finding | Grade |
|---|---|---|---|
| 14759755 | Caffeine | Significant improvements in attention, vigilance, and reaction time vs. placebo | A |
| 11790213 | Coffee/Caffeine | 32% reduced Parkinson's risk with habitual coffee intake | B |
| 12093601 | Bacopa Monnieri | Significant improvements in verbal learning and delayed recall at 300mg/day over 12 weeks | B |
| 24252493 | Bacopa Monnieri | Meta-analysis confirms consistent benefits on free recall memory across 9 RCTs | B |
| 1678027 | Phosphatidylserine | 15% improvement in memory tasks in age-associated memory impairment patients | B |
| 20190010 | Phosphatidylserine | 100mg PS improved memory recall and attention over 6 months in elderly subjects | B |
| 20091579 | Ginkgo Biloba | 120-240mg daily improved cognitive function in dementia patients | B |
| 10890298 | Ginkgo Biloba | Single 120mg dose enhanced speed of attention at 2.5 and 6 hours post-dose | B |
Overall Evidence Grade: B — Multiple double-blind RCTs confirm memory and recall benefits; 8-12 week onset latency and stronger evidence in aging populations limit Grade A designation for general healthy adults.
| Ingredient | Dose | Primary Mechanism | Key Benefit |
|---|---|---|---|
| Arabica Coffee | Standard | Adenosine receptor antagonism | Acute alertness & focus |
| Bacopa Monnieri | 300mg | Acetylcholinesterase modulation, BDNF upregulation | Memory & learning |
| Phosphatidylserine | 100mg | Membrane fluidity, neurotransmitter release | Cognitive processing |
| Ginkgo Biloba | 120mg | Cerebral blood flow, antioxidant | Focus & neuroprotection |
| User Level | Dose | Timing | Notes |
|---|---|---|---|
| Beginner | 1 sachet daily | Morning with breakfast | Start with food to assess tolerance; evaluate response over 2-4 weeks |
| Intermediate | 1 sachet daily | Morning, 30 min before cognitive tasks | Optimal for work/study sessions; maintain for 8-12 weeks for full Bacopa benefit |
| Advanced | 1 sachet morning | Morning focus session | May stack with omega-3 DHA for synergistic membrane support |
Preparation:
V-NEUROKAFE has a well-established safety profile based on the clinical literature for all four ingredients.
Contraindications:
A: V-NEUROKAFE delivers a two-phase response. Acute effects from caffeine and Ginkgo are noticeable within 1-2.5 hours — improved alertness, focus, and reaction time. The memory and learning benefits from Bacopa and Phosphatidylserine require 8-12 weeks of consistent daily use to reach peak effect, as documented in the Roodenrys 2002 trial (PMID 12093601).
A: Clinical trials consistently use 300mg/day of standardized extract containing 45-55% bacosides. This is the exact dose in V-NEUROKAFE. The Kongkeaw 2014 meta-analysis (PMID 24252493) confirmed this range produces statistically significant improvements in free recall, learning rate, and cognitive processing.
A: Yes. V-NEUROKAFE stacks well with omega-3 DHA (synergistic membrane support), Lion's Mane Mushroom (NGF stimulation), and CDP-Choline (additional acetylcholine precursor). Avoid combining with additional high-caffeine products. Those on anticoagulants should avoid adding high-dose fish oil (>3g EPA/DHA) due to combined antiplatelet effects with Ginkgo.
A: Research supports benefit in three key groups: (1) Adults 40-65 with age-associated memory concerns; (2) Students and knowledge workers requiring sustained cognitive performance; (3) Professionals in high-cognitive-load environments seeking both acute focus and long-term neuroprotection. Not recommended for pregnant/breastfeeding women, caffeine-sensitive individuals, or those on anticoagulant therapy without medical clearance.
A: Side effects are generally mild and infrequent. Bacopa may cause GI discomfort in 10-15% of users (take with food). Caffeine may cause jitteriness in sensitive individuals. Ginkgo has rare interactions with blood thinners. In clinical trials, Phosphatidylserine showed no significant adverse events compared to placebo.
Experience the synergistic power of Bacopa Monnieri, Phosphatidylserine, and Ginkgo Biloba — delivered in your daily coffee ritual. Backed by 8 peer-reviewed studies and an Evidence Grade of B.
Shop V-NEUROKAFE Now